NYSE ARCA | ETF
Under normal circumstances, the fund invests at least 80% of its net assets in equity securities of mid-cap companies.
Equity securities include common or preferred stocks that are listed onU. S. exchanges.
It may invest a significant portion of its assets in the securities of companies conducting business within a single sector.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| FTAI | FTAI Aviation Ltd. | Industrials | Rental & Leasing Services | 6.58% |
| KYG3730V1059 | FTAI AVIATION LTD | 6.02% | ||
| PDPG | Liberty International Holding Corp | Consumer Defensive | Beverages - Non-Alcoholic | 5.10% |
| NBIS | Nebius Group N.V. | Communication Services | Internet Content & Information | 4.78% |
| FWONK | Liberty Media Corporation Series C Liberty Formula One Common Stock | Communication Services | Entertainment | 4.74% |
| GFL | Gfl Environmental Holdings Inc | Industrials | Waste Management | 4.57% |
| FIX | Comfort Systems USA Inc | Industrials | Engineering & Construction | 4.20% |
| MU | Micron Technology Inc | Technology | Semiconductors | 4.17% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 3.82% |
| TLN | Talen Energy Corporation | Utilities | Utilities - Independent Power Producers | 3.81% |
| HEI-A | HEICO Corporation | Industrials | Aerospace & Defense | 3.77% |
| TLNE | Talen Energy Corporation | Utilities | Utilities - Independent Power Producers | 3.64% |
| VLTO | Veralto Corporation | Industrials | Pollution & Treatment Controls | 3.49% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.46% |
| RGEN | Repligen Corporation | Healthcare | Medical Instruments & Supplies | 3.35% |
| DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 3.23% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.21% |
| MDB | MongoDB | Technology | Software - Infrastructure | 3.12% |
| SE | Sea Ltd | Consumer Cyclical | Internet Retail | 2.98% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.88% |